8 reports of this reaction
4.3% of all DIPHENHYDRAMINE CITRATE, IBUPROFEN reports
#1 most reported adverse reaction
FATIGUE is the #1 most commonly reported adverse reaction for DIPHENHYDRAMINE CITRATE, IBUPROFEN, manufactured by Family Dollar (FAMILY WELLNESS). There are 8 FDA adverse event reports linking DIPHENHYDRAMINE CITRATE, IBUPROFEN to FATIGUE. This represents approximately 4.3% of all 188 adverse event reports for this drug.
Patients taking DIPHENHYDRAMINE CITRATE, IBUPROFEN who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among DIPHENHYDRAMINE CITRATE, IBUPROFEN users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for DIPHENHYDRAMINE CITRATE, IBUPROFEN:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 8 FDA reports for DIPHENHYDRAMINE CITRATE, IBUPROFEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 4.3% of all adverse event reports for DIPHENHYDRAMINE CITRATE, IBUPROFEN, making it one of the most commonly reported side effect.
If you experience fatigue while taking DIPHENHYDRAMINE CITRATE, IBUPROFEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.